Mary E.D. Flowers

1990–2024 年に発表

167
論文数
41,390
被引用数
104
h 指数
167
i10 指数

被引用数

Mary E.D. Flowers の年別被引用数1976 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 3 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 5 件1997 年: 被引用 8 件1998 年: 被引用 18 件1999 年: 被引用 27 件2000 年: 被引用 46 件2001 年: 被引用 87 件2002 年: 被引用 163 件2003 年: 被引用 222 件2004 年: 被引用 163 件2005 年: 被引用 199 件2006 年: 被引用 219 件2007 年: 被引用 217 件2008 年: 被引用 230 件2009 年: 被引用 273 件2010 年: 被引用 273 件2011 年: 被引用 331 件2012 年: 被引用 326 件2013 年: 被引用 289 件2014 年: 被引用 294 件2015 年: 被引用 324 件2016 年: 被引用 314 件2017 年: 被引用 254 件2018 年: 被引用 201 件2019 年: 被引用 997 件2020 年: 被引用 1,162 件2021 年: 被引用 967 件2022 年: 被引用 720 件2023 年: 被引用 475 件2024 年: 被引用 1,058 件2025 年: 被引用 298 件2026 年: 被引用 2 件1977〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,811 件、この内訳の 28.4%ドイツ: 引用元論文 715 件、この内訳の 7.2%フランス: 引用元論文 583 件、この内訳の 5.9%イタリア: 引用元論文 558 件、この内訳の 5.6%イギリス: 引用元論文 554 件、この内訳の 5.6%中国: 引用元論文 425 件、この内訳の 4.3%スペイン: 引用元論文 389 件、この内訳の 3.9%オランダ: 引用元論文 346 件、この内訳の 3.5%カナダ: 引用元論文 334 件、この内訳の 3.4%日本: 引用元論文 291 件、この内訳の 2.9%スイス: 引用元論文 266 件、この内訳の 2.7%オーストラリア: 引用元論文 253 件、この内訳の 2.6%
0%28.4%その他 24%

分野

  • Medicine89.2%
  • Immunology and Microbiology5.1%
  • Biochemistry, Genetics and Molecular Biology3.2%
  • Engineering0.7%
  • Psychology0.3%
  • Dentistry0.2%
  • その他1.3%

トピック

  • Hematopoietic Stem Cell Transplantation19.3%
  • Acute Myeloid Leukemia Research6%
  • Acute Lymphoblastic Leukemia research4.6%
  • Immune Cell Function and Interaction4.6%
  • T-cell and B-cell Immunology4.1%
  • Cytomegalovirus and herpesvirus research2.9%
  • その他58.5%

共著者

全論文

検索で開く
  1. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2014 被引用: 5,394

  2. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    著者: , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2008 被引用: 1,906

  3. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2005 被引用: 3,530

  4. Ibrutinib for chronic graft-versus-host disease after failure of prior therapy

    著者: , , , , , , , , , , , , , , , , - Blood 2017 被引用: 499

  5. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

    著者: , , , , , , , , , , , , , - Bone Marrow Transplantation 2018 被引用: 491

  6. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 被引用: 419

  7. Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Peter Gale, John Koreth, Nelson J. Chao, Mahmoud Aljurf, Brenda Cooper, Mary J. Laughlin, Jack W. Hsu, Peiman Hematti, Leo F. Verdonck, Melhelm M. Solh, Maxim Norkin, Vijay Reddy, Rodrigo Martino, Shahinaz M. Gadalla, Jenna D. Goldberg, Philip L. McCarthy, Josè Antonio Pérez-Simón, Nandita Khera, Ian D. Lewis, Yoshiko Atsuta, Richard F. Olsson, Wael Saber, Edmund K. Waller, Didier Blaise, Joseph A. Pidala, Paul J. Martin, Prakash Satwani, Martin Bornhäuser, Yoshihiro Inamoto, Daniel J. Weisdorf, Mary M. Horowitz, Steven Z. Pavletic - Biology of Blood and Marrow Transplantation 2014 被引用: 435

  8. Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium

    著者: , , , , , , , , , , , , - Blood Advances 2021 被引用: 140

  9. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

    著者: , , , , , , , , , , , , , , , - Blood 2011 被引用: 681

  10. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Transplantation and Cellular Therapy 2021 被引用: 167

  11. How we treat chronic graft-versus-host disease

    著者: , - Blood 2014 被引用: 374

  12. Risk factors for acute GVHD and survival after hematopoietic cell transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2011 被引用: 697

  13. Cord-Blood Transplantation in Patients with Minimal Residual Disease

    著者: , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 441

  14. Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study

    著者: , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2019 被引用: 112

  15. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Robinson, Michael E. Ward, Bryce B. Reeve, Lisa G. Rider, Howard M. Shulman, Kirk R. Schultz, Daniel Weisdorf, Georgia B. Vogelsang - Biology of Blood and Marrow Transplantation 2006 被引用: 565

  16. Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

    著者: , , , , , , , , , - Blood 2016 被引用: 228

  17. Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

    著者: , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 被引用: 177

  18. Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML

    著者: , , , , , , , , , , , , , , - Blood 2022 被引用: 81

  19. Chronic graft-versus-host disease

    著者: , , - Biology of Blood and Marrow Transplantation 2003 被引用: 954

  20. NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 被引用: 315

  21. Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK–modified donor T cells after allogeneic hematopoietic cell transplantation

    著者: , , , - Blood 2005 被引用: 338

  22. Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation

    著者: , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 被引用: 211

  23. Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 54

  24. Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

    著者: , , , , , , , , , - 1991 被引用: 802